Pariet and fasciitis Patient Reports February 11, 2012

Pariet Side Effects Report #5657912-0
Pariet side effect was reported by a Physician from JAPAN on Feb 27, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis , fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.

Pariet Side Effects Report #5729397-7
Pariet side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis , fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.

Pariet Side Effects Report #5729823-3
Pariet side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis , fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.

Pariet Side Effects Report #5730106-6
Pariet side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis , fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.